HELPING THE OTHERS REALIZE THE ADVANTAGES OF LENMELDY

The pill formulation of zanubrutinib (Brukinsa; BeOne) is currently authorised for all 5 indications across a number of hematological cancers.To make Libmeldy, the CD34+ cells (cells that can make white blood cells) are extracted in the blood or bone marrow. A gene enabling them to create ARSA is inserted into the CD34+ cells employing a variety of